Peter Libby, M.D. – Program co-chair Mallinckrodt Professor of Medicine Harvard Medical School

Jean-Claude Tardif, M.D. – Program co-chair Director, Research Center Montreal Heart Institute

Eric Abadie, M.D. Director, Therapeutics Evaluation, AFSSAPS European Medicines Agency (EMEA)

Christine Albert, M.D., MPH Director, Center for Arrhythmia Prevention Harvard Medical School Boston, MA

Jonathan Allis, M.D. Global Head of Imaging GE Healthcare Diagnostics

Todd Anderson, M.D. Director, Foothills Hospital

Naomi Aronson, Ph.D. Executive Director Technology Evaluation Center Blue Cross and Blue Shield Association Chicago, IL

Robert S. Balaban, M.D., Ph.D. National Heart, Lung and Blood Institute National Institutes of Health

Christie Ballantyne, M.D. Director, Ctr. for Cardiovascular Disease Prev. Baylor College of Medicine

Ruth Barrington, PhD, Chief Executive Officer, Molecular Medicine Ireland, Dublin Ireland

Frank Barry, PhD, Director, National Centre for Biomedical Engineering Science, National University Ireland, Galway

Thomas Barry, PhD, Molecular Diagnostics Research Group, National University of Ireland, Galway

Philip Barter, M.D. Professor of Medicine University of Sydney

Russell Basser, M.D. Global Director of Clinical Development CSL, Ltd.

Philippe Bedard, M.D. Asst. Professor Princess Margaret Hospital, Toronto

Colin Berry, BSc., M.D., Ph.D. Cardiovascular MRI / CV Intervention Program NHLBI, National Institutes of Health

Donald M. Black, MBA, M.D. Global Head of Research and Development General Electric Healthcare President, Trialynx Inc.

Sandra Black, M.D. Brill Chair in Neurology Sunnybrook Health Sciences Centre, Toronto

Melanie Blank, M.D. Division of Cardiovascular and Renal Products CDER, FDA

Eric P. Brass, M.D., Ph.D. Professor of Medicine Harbor-UCLA Medical Center

H. Bryan Brewer, Jr., M.D. Director of Lipoprotein and Atherosclerosis Research MedStar Research Institute

Greg Brown, M.D., Ph.D. Proffessor of Medicine University of Washington

David G. Brown, Ph.D. NIBIB/CDRH Laboratory for the Assessment of Medical Imaging Systems US FDA

W. Virgil Brown, M.D. Charles Howard Candler Professor of Medicine Emory University School of Medicine Atlanta, GA

Michael A. Browlee, MD Albert Einstein College of Medicine

Diarmuid Cahalane, Founder of Open Innovation Partners Ltd, Cork Ireland

Dolores Cahill, PhD, Professor of Translational Science, University College Dublin, Ireland

Gloria Crispino, PhD,Clinical Trial Statistician , Institute of Technology Tallaghat , Dublin, Ireland

Robert M. Califf, M.D. Vice Chancellor for Clinical Research Director, Duke Translational Medicine Institute Durham, NC

Gregory Campbell, Ph.D. Director, Division of Biostatistics US FDA, CDRH

Christopher Cannon, M.D. Associate Prof. of Medicine, Brigham and Women's Hospital

Gao Chenyan, M.D. Director of Division VII Center of Drug Evaluation, China SFDA Beijing, China

Eric Colman, M.D. Division of Metabolism and Endocrine Center for Drug Evaluation and Research, US FDA

Carolyn C. Compton, M.D., Ph.D. Director, Office of Biorepositories and Biospecimen Research (OBBR) National Cancer Institute, National Institutes of Health

Douglas Cowart, Pharm.D. Association of Clinical Research Organizations

Janet Dancey, M.D. Director, Clinical Translational Research NCIC Clinical Trials Group, Ontario

Hayes Dansky, M.D. Director, Cardiovascular Disease Merck Research Laboratories

Michael Davidson, M.D. Director of Preventive Cardiology University of Chicago School of Medicine

Jill Davies, M.Sc, Genetic Counsel Program Director, MedCan Clinic

Jean Davignon, M.D. Director Hyperlipidemia and Athero Research Clinical Research Institute of Montreal Professor of Medicine, University of Montreal Montreal, Quebec

John Deanfield

British Heart Foundation

Clarissa Desjardins, PhD, CEO Center of Excellence in Personalized Medicine

James De Lemos, M.D. Associate Professor and CCU Director University of Texas-Southwestern Medical School

Marcelo Di Carli, M.D. Chief, Nuclear Medicine Brigham and Women's Hospital

Pamela S. Douglas, M.D. Director, DCRI CV Imaging Program Duke University Medical Center

Elizabeth Eisenhauer, M.D. Professor, Dept. of Oncology Queens Univ. Canadian Cancer Research Alliance

Benjamin Eloff, Ph.D. Office of Scientific and Medical Programs Office of the Commissioner, US FDA

Zahi A. Fayad, Ph.D. Professor, Departments of Radiology and Med. Mount Sinai School of Medicine

Mark Ferguson, PhD, Director General, Science Foundation Ireland

Giora Feuerstein, MD Head, Discovery Translational Medicine Wyeth Research

Uri Frank, PhD, National Centre for Biomedical Engineering Science, National University of Ireland, Galway

Felix W. Frueh, Ph.D. Vice President, R&D Personalized Medicine Medco Health Solutions, Inc.

Brandon D. Gallas, PhD,NIBIB/CDRH Laboratory for the Assessment of Medical Imaging Systems US FDA

Jean-Jacques Garaud, M.D. Head of Global Drug Development F. Hoffmann-La Roche Ltd

Alan J. Garber, M.D., Ph. D. Professor, Medicine, Biochemistry, Molecular and Cellular Biology Baylor College of Medicine Houston, TX

Marcie Glicksman, Ph.D. Asst. Professor, Neurology Brigham and Women's Hospital

Anne Goodbody, PhD, Director Ontario Institute for Cancer Research

Federico Goodsaid, Ph.D. Office of Clinical Pharmacology Center for Drug Evaluation and Research, US FDA

Mark Grant, M.D. Senior Scientist, Technology Evaluation Center Blue Cross Blue Shield Association

Steven Gutman, M.D. Director, Office of In Vitro Diagnostic Device Evaluation and Safety Center for Devices and Radiologic Health, FDA Silver Spring, MD

Rory Hachamovitch, M.D. Department of Medicine University of Southern California Los Angeles, CA

Robert Harrington, M.D. Duke University

Patricia P. Harlow, Ph.D. Division of Cardiovascular and Renal Drug Products US FDA, CDER

Thomas Hatsukami, M.D. Vascular Surgery, Washington University

Stan Hazen, M.D. Cleveland Clinic Foundation

Jay Heinecke, M.D. Professor of Medicine University of Washington

Therese Heinonen, D.V.M. Associate Director, Medical and Science Affairs, Montreal Heart Institute Coordinating Center

Chris Howard, Solution Architect, IBM Innovation Centre, Dublin, Ireland

Thomas Hudson, M.D. President and Scientific Director Ontario Institute for Cancer Research

Seigo Izumo, M.D., Ph.D. Vice President and Global Head CV Research Novartis Institute for Biomedical Research

Ilan Irony M.D. Clinical Team Leader DMEP, OND, CDER, US FDA

Hylton Joffe, M.D. Division of Metabolism and Endocrine Center for Drug Evaluation and Research, US FDA

Dominique Johnson, Ph.D. Director Montreal Heart Institute Coord. Center

Lokesh Joshi, PhD,Director, Alimentary Glycoscience Research Clusher, National University Ireland, Galway

Koen Kas, PhD, Professor, University Ghent, CSO, Pronota, Ghent, Belgium

John Kastelein Chair, Genetics in CV Disease, University of Amsterdam

Cormac Kilty, PhD, Chief Technical Officer, EKF, Diagnostics, London England

Agnes Klein, M.D. Director, Ctr. for Eval. Of Radiopharm. And Biotherapeutics, Health Canada

Michael Klimas, Ph.D. Executive Director, Imaging Franchise Lead Merck & Co., Inc.

Wolfgang Koenig, M.D. Professor of Medicine and Cardiology University of Ulm Medical Center, Ulm Germany

Reijo Laaksonen, MD, PhD, Chief Medical Officer and Co-Founder, Zora Biosciences, Espoo Finland

Hanno Langen, PhD, Global Head of Protein and Metabolite Technologies, Hoffman-LaRoche, Basel Switzerland

Lewis Kuller, M.D. Chair Epidemiology, University of Pittsburgh

Jeff Leiden, M.D., Ph.D. Managing Director Clarus Ventures

Lawrence Leiter, M.D. Head, Endocrinology and Metabolism St. Michael's Hospital, Toronto

Claude Lenfant, M.D. Director, NIH, NHLBI

Daniel Levy, MD Director, Framingham Heart Study Director, Center for Population Studies National Heart, Lung, & Blood Institute Bethesda, MD

Robyn Lim, Ph.D. Scientific Advisor Office of Legislative and Regulatory Modernization Health Canada

João A.C. Lima, M.D. Assoc. Prof. of Med., Rad. and Epidemiology Johns Hopkins University

Ray Lipicky, M.D. Former Director, Cardio-Renal, FDA

Peter Liu, M.D.,Scientific Director Canadian Institutes of Health Research

Klas Malmberg, M.D., PhD. Karolinska Institute

Elizabeth Mansfield, Ph.D. Senior Policy Analyst, Office of In Vitro Diag. Device Eval. and Safety, CDRH, USFDA

Bruce McManus, M.D., Ph.D. Professor and Director, The James Hogg iCAPTURE Centre University of British Columbia - St. Paul's Hospital Scientific Director, The Heart Centre - Providence Health Care Vancouver, British Columbia

David O. Meltzer, M.D., Ph.D. Director of the Center for Health and Social Sciences Department of Medicine and Dept. of Economics University of Chicago Chicago, IL

George A. Mensah, M.D. National Ctr. for Chronic Disease Prevention and Health Prom.Centers for Disease Control and Prevention

Michele Mercuri, M.D., Ph.D. Head Pharma Scientific Review Committee Novartis Pharmaceuticals Corp.

Pierre Meulien, PhD, President and Chief Executive Officer, Genome Canada

George Mills, M.D. Vice President, Medical Imaging Consulting Perceptive Informatics

Gary F. Mitchell, M.D. Cardiovascular Engineering, Inc. Waltham, MA

Jacques Mizrahi, M.D. Head, Metabolic Diseases F. Hoffmann-LaRoche

Vincent Mooser, M.D. Clinical Pharmacology and Disc. Med. GlaxoSmithKline

C. Daniel Mullins, PhD. Professor, Pharmacoeconomics University of Maryland

Elizabeth Nabel, M.D. Director, NHLBI, NIH

Ilaria Nardello, National University of Ireland, and National Coordinator, the Marine Institute, Ireland

Steve Nissen, M.D. Director, Cleveland Clinic Foundation

Minh Nguyen, M.D. University of Florida

Christopher O'Donnell, M.D. Senior Advisor, Genome Research NHLBI, National Institutes of Health

Daniel O'Leary, M.D. Chairman Radiology, New England Medical Center

Patrick O'Mahony, DVM, MBA  Executive Director,Irish Medicnes Board, Chairman, European Medicines Agency (EMA), Dublin, Ireland

Brian O’Neill, PhD, Manager of Life Sciences, Enterprise Ireland

David Orloff, M.D. Executive Director, Reg Affairs Medpace Inc.

Abhay Pandit, PhD, Director, Network of Excellence for Functional Biomaterials, National University Ireland, Galway

Mary Parks, M.D. Division of Metabolism and Endocrine Center for Drug Evaluation and Research, US FDA

Gerard Pasterkamp, MD, PhD, Chief Scientific Officer, Cavadis, Experimental Cardiology Laboratory, University Medical Center Utrecht, The Netherlands

Michael Perelman, M.D. Vice President, Global Project Mgmt Schering-Plough Research Institute

Marc Pfeffer, M.D., Ph.D. Professor of Medicine Harvard Medical School Boston, MA

Michael S. Phillips, Ph.D. Director of Pharmacogenomics Genome Quebec Montreal, Quebec

Hubert Pouleur, MD, PhD, Vice President, Cardiovascular-Metabolic Disease Strategy, Pfizer Inc. New York, NY- USA

Robert Powell, PharmD Director, Pharmacometrics Office of Clinical Pharmacology Center for Drug Evaluation and Research US Food and Drug Administration Silver Spring, MD

Daniel Rader, M.D. University of Pennsylvania

Paolo Raggi, M.D. Director, Preventive Cardiology, Tulane

Joel Raichlen, M.D. Senior Director, Clinical Research Astra-Zeneca

Gurvaneet Randhawa, M.D. Center for Outcomes and Evidence Agency for Healthcare Research and Quality

Patricia Reilly, Member of the Cabinet of Maire Geoghegan-Quinn, European Commissioner for Research, Innovation and Science, Dublin, Ireland

Paul M. Ridker, M.D. Center for Cardiovascular Disease Prevention Brigham and Women’s Hospital

Dwaine Rieves, M.D. Director, Medical Imaging Center for Drug Evaluation and Research, US FDA

John Rioux, Ph.D. The Lab of Genetics and Genomic Med of Inflam., Montreal Heart Institute

Robert Roberts M.D. President and CEO University of Ottawa Heart Institute

Jean Rouleau, M.D. Dean of Medicine University of Montreal

Army E. Rudolph, Ph.D. Director, Glob. Med CV Metabolic Endocrine Pfizer, Inc.

Kerry-Anne Rye, Ph.D. Head, Lipid Research Group The Heart Research Institute, Sydney, AU

Philip Sager, M.D. Chief Medical Officer CardioDx, Inc.

William J. Sasiela, Ph.D. Chief Medical Officer Aegerion Pharmaceuticals, Inc.

Ernst Schaefer, M.D. Director, Lipid Metabolism Laboratory Tufts University Boston, MA

Patrice Sarrizin, Ph.D. Senior Scientific Evaluator In Vitro Diagnostic Devices Health Canada

Daniel Schultz, M.D. Director, Center for Devices and Radiological Health US Food and Drug Administration Rockville, MD

Sonia Skarlatos Ph.D. Deputy Director Devision of Cardiovascular Sciences National Heart, Lung, and Blood Institute, NIH

David Smalley, Ph.D. Assistant Professor Cardiovascular Research Center University of Virginia

Carl Sparrow, Ph.D. Director, Lipid Biochemistry Merck Research Laboratories

J. David Spence, M.D. Director, Stroke Prevention and Athero Research Centre Robarts Research Institute London, Ontario, CANADA

Ton van der Steen, Ph.D. Biomedical Tech in Cardiologym Thorax Center, Rotterdam

George Steiner, M.D. University of Toronto

Norman Stockbridge, M.D. Division of Cardio-Renal, Center for Drug Evaluation and Research, US FDA

Erik Stroes, M.D., Ph.D. Department of Vascular Medicine Academic Medical Center, Amsterdam

Anders Svensson, M.D. Head of Clinical Development - Metabolism F. Hoffman-LaRoche, Ltd.

Alan Tall, M.D. Professor of Medicine Columbia University

Allen Taylor, M.D. Chief, Cardiology Service Walter Reed Army Medical Center

Ahmed Tawakol, M.D. Professor of Medicine Massachusetts General Hospital

Robert Temple, M.D. Director, Office of Medical Policy US FDA

Douglas C. Throckmorton, M.D. Deputy Center Director, Center for Drug Evaluation and Research, US FDA

Paula R. Trumbo, Ph.D. Team Leader, Nutrition Science Eval. Center for Food Safety and App. Nutrition, US FDA

Roger Ulrich, Ph.D. Chief Development Officer Callistoga Pharmaceuticals

Spiros Vamvakas, Head of Section for Scientific Advice, European Medicines Agency

Karin Wahlander, MD,PhD, Vice President for Translational Science, Astra Zeneca , Sweden

John Wagner, MD, Ph.D. Director, Clinical Pharmacology Merck & Co., Inc.

David Waters, M.D. Chief, Cardiovascular Medicine University of California, San Francisco

G. Russell Warnick, M.S., MBA Chief Scientific Officer Berkeley HeartLab, Inc.

Ralph Weissleder, M.D., Ph.D. Director, Center for Molecular Imaging Research Professor of Radiology, Harvard Medical School Boston, MA

James J. Zhang, M.D., Ph.D., MBA Global Clinical Development Siemens Molecular Imaging, Inc. Siemens Medical Solutions USA

Bram Zuckerman, M.D. Director, Center for Devices and Radiological Health, US FDA